OxTalks is Changing
During Michaelmas Term, OxTalks will be moving to a new platform (full details are available on the Staff Gateway).
For now, continue using the current page and event submission process (freeze period dates to be advised).
If you have any questions, please contact halo@digital.ox.ac.uk
Cannabidiol as a treatment for acute cannabis intoxication in schizophrenia and schizoaffective disorder
Cannabidiol is being investigated as a novel treatment for both psychosis and cannabis use disorder. There is also evidence from experimental studies in healthy volunteers that is can reduce the acute adverse effects of cannabis intoxication. In this talk, Dr Chesney will describe a randomised placebo controlled trial investigating if a large oral dose of CBD can reduce the adverse effects of vaporised cannabis in individuals with schizophrenia and schizoaffective disorder.
zoom.us/j/97234106780?pwd=OEtUaDJsS3UrUklhZHRyOFVDK3p0Zz09
Meeting ID: 972 3410 6780
Passcode: 004054
Date:
16 January 2024, 9:30
Venue:
Department of Psychiatry, Headington OX3 7JX
Venue Details:
Seminar Room
Speaker:
Dr Edward Chesney (Kings College London)
Organising department:
Department of Psychiatry
Organiser contact email address:
rania.elgarf@psych.ox.ac.uk
Host:
Philip McGuire (University of Oxford)
Part of:
Psychiatry Seminar Series
Booking required?:
Not required
Audience:
Public
Editors:
Katherine Shepherd,
Rania Elgarf
